How similar is your biosimilars?
Somru BioScience Inc. has developed an intelli.b™ platform for comparability testing of biologics? Biosimilars at molecular level that meets the intent of the FDA guidance for fingerprint-like analysis.
Read moreAMPLATTO™
DETECTION
Ultra-sensitive immunoassay solutions for
low-abundance biomarker and impurity detection
Ultra-Sensitive
Detection
Detection
High Specificity
& Accuracy
& Accuracy
Reliable &
Reproducible
Reproducible
Streamlined
Workflows
Workflows
SOMRU BIOSCIENCE INC. ACCELERATING YOUR DRUG DEVELOPMENT
Accelerating Biosimilars Development
The rise of biosimilars has provided challenges and opportunities in equal measure for biotechnology, biopharmaceutical and bioanalytical contract research organizations (CROs). Somru BioScience Inc. has developed a portfolio of reagents, tools, solutions and a knowledge database that will enable companies to capitalize on biosimilar opportunities. We provide comprehensive expertise and solutions to reduce both the time and cost of your biosimilar development programs.
Read moreScientific Insights
Stay updated with the latest insights, research developments, and industry news from Somru BioScience Inc. Explore our expert perspectives on biosimilars, immunogenicity, biomarker testing, and cutting-edge biopharmaceutical innovations.
Immunogenicity ELISA
Somru BioScience Inc. offers high quality, sensitive and robust off-the-shelf ELISA kits for the measurement of anti-drug antibodies (i.e. both anti-innovator and anti-biosimilar) in biological matrices.
Read more
Biomarker Testing Solutions
Biomarkers have become an integral part of the decision-making process not only in the personalized drug development process, but also in biosimilar and biobetter drug development.
Read morePRODUCT CATEGORY
Explore our comprehensive portfolio of biopharmaceutical products and solutions. From advanced antibody detection kits to cutting-edge biomarker assays, Somru BioScience Inc. provides the tools you need to accelerate your drug development and research programs.
LATEST NEWS
17JUN
Canadian CRO Somru BioScience Inc. Acquires Bangladesh Based Novus Clinical Research Services Limited to Expand Global Clinical Research Network
Somru BioScience Inc., a Prince Edward Island headquartered Canadian biotechnology company and contract research organization (CRO), today announced that its Bangladesh affiliate, Somru BioScience (BD) Limited, has signed a definitive agreement to acquire 100% of the shares of Novus Clinical Research Services Limited, one of Bangladesh's established contract research organizations.
01JUN
Somru BioScience to Attend BIO International Convention 2026 in San Diego
Charlottetown, Prince Edward Island — June 2026 Somru BioScience Inc. is pleased to announce its participation in the BIO International Convention 2026 , taking place from June 22–25, 2026 , in San Di
13MAY
Welcoming the Honourable Mélanie Joly, Canada’s Minister of Industry, to Somru BioScience Inc.
We were delighted to welcome the Honourable Mélanie Joly Canada’s Minister of Industry, to Somru BioScience Inc. for a tour of our growing biomanufacturing facilities. It was an honour to showcase how